Fractyl ais a biotechnology company looking to bring curative therapies to the large populations of patients with metabolic disease.

Register for Details

For more details on financing and valuation for Fractyl, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Fractyl

Forge green plus iconForge green minus icon

What is Fractyl's funding to date?

Fractyl has raised $286.48MM to date.
Forge green plus iconForge green minus icon

When was Fractyl founded?

Fractyl was founded in 2010.

Fractyl Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
6/16/2021 Series F $100MM raised $XXX.XX $XXX.XX
8/6/2020 Series E $55.07MM raised $XXX.XX $XXX.XX
11/30/2017 Series D $43.98MM raised $XXX.XX $XXX.XX
11/19/2015 Series C-1 and C-2 $67.43MM raised $XXX.XX $XXX.XX
3/21/2013 Series B $14.5MM raised $XXX.XX $XXX.XX
6/15/2011 Series A $5.5MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Jun 13, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.